Related by context. All words. (Click for frequent words.) 76 Peripheral Arterial 74 Patients Undergoing 72 Atypical Hemolytic Uremic Syndrome 72 Patients Treated With 72 Heart Failure Patients 71 Successfully Treats 70 Meets Primary Endpoint 70 Successfully Treated 70 induce orthostatic hypotension 70 Dual Antiplatelet Therapy 70 Knee Osteoarthritis 70 myelodysplastic myeloproliferative diseases 70 Myocardial Ischemia 70 Left Ventricular 70 Ischemic 70 Thromboembolic 70 Improves Outcomes 70 Refractory Hodgkin Lymphoma 70 Chronic Bronchitis 70 Prospective Randomized 69 Renal Artery 69 Secondary Hyperparathyroidism 69 NAVISTAR R 69 Clinical Outcome 69 Intracranial 69 Adjuvant Chemotherapy 69 ST Elevation Myocardial 69 Disease Progression 69 Endometrial 69 Renal Impairment 69 Adjuvant Treatment 69 Intravascular 69 Aliskiren 69 Endothelial 69 Hyperlipidemia 69 Initiates Clinical Trial 69 PAOD 69 Polyneuropathy 69 Patients Receiving 69 Aortic Valve 69 Ischemia 69 Esophagitis 69 Antitumor Activity 69 Acute Myocardial Infarction 69 J Am Coll 69 Thromboembolism 69 Pulmonary Embolism PE 69 Esophageal 69 Pivotal Trial 69 Hypotension 69 Embolization 68 Catheter Ablation 68 Hypertrophic 68 Infarction 68 Skeletal Muscle 68 Autologous Stem Cell Transplantation 68 Infarct 68 Metastases 68 secondary hyperparathyroidism 68 Radiofrequency Ablation 68 Phase 2b Clinical Trial 68 Intravitreal 68 Renal Function 68 Cardiovascular Outcomes 68 Naive Patients 68 Treating Chronic 68 Novel Oral 68 Elderly Patients 68 Chronic Heart Failure 68 Unfractionated Heparin 68 occlusive disease 68 Fracture Risk 68 Delayed Graft Function 68 MR Angiography 68 R Saizen R 68 Complicated Skin 68 Primary Hypercholesterolemia 68 Stenosis 68 Improves Survival 68 Hypertrophy 68 Microalbuminuria 68 Adjunctive 68 Thiazolidinediones 68 Advanced Melanoma 67 Chronic Sinusitis 67 Bone Metastases 67 Reperfusion Injury 67 Previously Treated 67 Acute Ischemic Stroke 67 Patients Treated 67 Hyperphosphatemia 67 Prophylactic Treatment 67 Improve Survival 67 Severe Sepsis 67 Hemolysis 67 Progressive Multifocal Leukoencephalopathy 67 Eculizumab 67 hypervascular tumors 67 Drug Candidate 67 Abciximab 67 metastatic malignant 67 Diabetic Neuropathy 67 Shows Promise Against 67 Prolongs Survival 67 Acute Myocardial 67 Mitral Regurgitation 67 Metastatic Colorectal Cancer 67 Chemoradiation 67 Myelodysplastic Syndrome 67 Mouse Model 67 Coronary Artery Bypass Graft 67 bullous 67 Levels Linked 67 Demonstrates Positive 67 Contrast Agent 67 Oral Fingolimod 67 occlusion CRVO 67 Degarelix 67 acute humoral rejection 67 treat chronic sinusitis 67 Glioblastoma Multiforme 67 Zollinger Ellison Syndrome 67 Risk Stratification 67 Central Retinal Vein 67 Patency 67 Preclinical Study 67 Slow Progression 67 Vertebral Compression Fractures 67 Ischemic Stroke 67 superficial femoral 67 erythematosus 67 Overactive Bladder 67 Achieves Primary Endpoint 67 B Cell Lymphoma 67 Fondaparinux 67 Minimally Invasive Procedure 67 Clinical Trial Results 67 chronic thromboembolic pulmonary 67 Carotid Stenting 67 Drug Prevents 67 Nebulized 67 myocardial infarction ventricular fibrillation 67 Cardiovascular Events 67 Squamous Cell Carcinoma 67 TNF Tumor Necrosis Factor 67 Initiate Clinical Trial 67 Hormone Refractory Prostate Cancer 67 complement inhibitor eculizumab 67 Ventricular Tachycardia 67 Carcinoma 67 hyperphenylalaninemia HPA due 67 Anthracycline 67 endoluminal stent graft 67 Gene Mutation 66 Resection 66 Oral Mucositis 66 Platelet Inhibition 66 Adenomas 66 esophagogastric 66 treating abdominal aortic 66 Tyrosine Kinase Inhibitor 66 Advanced Renal Cell 66 Myelodysplastic Syndrome MDS 66 Surgical Treatment 66 Recurrent Breast Cancer 66 dual endothelin receptor antagonist 66 Mg Usa 66 Intracerebral Hemorrhage 66 Anti VEGF 66 NASH Huntington 66 Rheumatoid Arthritis Patients 66 Coronary Angiography 66 Hypercholesterolemia 66 Cypher Sirolimus 66 REMINDER ORLive Presents 66 Non Alcoholic Fatty 66 candesartan cilexetil 66 Chronic Renal Failure 66 Renal Cell Carcinoma 66 Alveolar 66 atypical Hemolytic Uremic Syndrome 66 leiomyomas 66 Arrhythmogenic 66 Idiopathic 66 Radioimmunotherapy 66 kidney urologic 66 ORLive Presents 66 Adenoma 66 Completes Patient Enrollment 66 CYT# potent vascular disrupting 66 J Am Acad 66 parathyroid carcinoma 66 Pivotal Clinical Trial 66 Tumor Growth 66 Papillary 66 Diffuse Large B 66 Carotid 66 Pulmonary Arterial Hypertension 66 Unstable Angina 66 Statin Therapy 66 Anti Tumor Activity 66 aneurysms AAA 66 Meta Analysis 66 nephrogenic fibrosing dermopathy 66 underlying vasculopathy 66 treat benign prostatic 66 Thrombotic 66 pulmonary alveolar 66 Stenting 66 Inhaled Corticosteroids 66 Reduces Mortality 66 Diabetic Nephropathy 66 Systemic lupus erythematosus 66 Catheter Associated 66 Completes Enrollment 66 Idiopathic Pulmonary Fibrosis 66 gastrointestinal stromal tumor 66 Hypertriglyceridemia 66 Pulmonary hypertension 66 INTEGRILIN R 66 R lenalidomide 66 Critical Limb Ischemia CLI 66 Lung Injury 66 Metastatic Melanoma 66 Microplasmin 66 Kidney Transplant Patients 66 unresectable tumors 66 Bucindolol 66 Adjuvant Therapy 66 Investigational Treatment 66 Diastolic Heart Failure 66 Safinamide 66 Ribavirin causes 66 cheilitis 66 Chronic Myeloid Leukemia 66 Neovascular Age Related Macular 66 Venous Thromboembolism 66 vapreotide acetate 66 Lowers Risk 66 malignant pleural effusion 66 Minimally Invasive Treatment 66 Deforolimus 66 FDA Approvals 66 migraines neurorehabilitation 66 First Patient Treated 66 Liver Injury 66 Replacement Therapy 66 familial hypercholesterolemia FH 66 chronic eosinophilic leukemia 66 Treatment Resistant 66 Parathyroid Hormone 65 Ureteral 65 Chronic Hepatitis C 65 Randomized Study 65 Hyperkalemia 65 intravascular hemolysis 65 Cardiotoxicity 65 Lupus Nephritis 65 Treatment Reduces 65 II Clinical Trial 65 lexidronam injection 65 artery stenosis 65 Malignant Melanoma 65 Exacerbation 65 central retinal vein 65 Chemotherapy Induced 65 Cholesterol Levels SPARCL 65 non resectable metastatic 65 Phase III Clinical Trial 65 Relapsing Multiple Sclerosis 65 Chronic HCV 65 Embolic 65 Drug Shows Promise 65 Endometrial Cancer 65 myelofibrosis polycythemia vera 65 Contrast Enhanced 65 Intra arterial 65 branch retinal vein 65 Relapsed Refractory 65 Benign Prostatic Hyperplasia BPH 65 Vitrasert R 65 rheumatoid arthritis osteoarthritis ankylosing 65 induced macular edema 65 Dose Ranging Study 65 Myocardial Infarction 65 Soft Tissue Sarcoma 65 Diabetic Patients 65 Chronic Liver Disease 65 Epidermal Growth Factor Receptor 65 psoriatic arthritis PsA 65 trial evaluating PRX# 65 targeted radiotherapeutic 65 descending thoracic 65 hyperprolactinemia 65 Breast Cancer Recurrence 65 Aneurysm Repair 65 Tumor Response 65 Low Dose 65 cytopenias 65 Benign Prostatic Hyperplasia 65 Files IND 65 lichen planus 65 Acute Coronary Syndromes 65 Sclerosing 65 Blood Clots 65 Demonstrates Efficacy 65 severe malignant osteopetrosis 65 Therapy Reduces 65 Clinical Trial Evaluating 65 Clinically Significant 65 Patient Outcomes 65 Sentinel Lymph Node Biopsy 65 ischemic mitral regurgitation 65 Asymptomatic 65 Dementia Related Psychosis 65 intimal hyperplasia 65 Intracoronary 65 Percutaneous Coronary Intervention 65 Transurethral 65 Cardiol 65 Seasonal Allergic Rhinitis 65 ST Segment Elevation 65 Randomized Double blind 65 Cyclooxygenase 2 65 homozygous familial hypercholesterolemia 65 Mouse Models 65 Unresectable 65 vitreous floaters 65 thalidomide Thalomid 65 Effectively Treats 65 Eisenmenger syndrome 65 primary hyperparathyroidism 65 Predict Risk 65 Motexafin Gadolinium 65 familial amyloidotic polyneuropathy FAP 65 Combination Treatment 65 Long Term Efficacy 65 acetonide FA 65 Allogeneic 65 hypertrichosis occurred 65 INCB# [003] 65 Neoadjuvant Chemotherapy 65 Gastric Cancer 65 Combination Therapy 65 arthritis PsA 65 capillary leak 65 Atherosclerotic 65 Regenerative Cells 65 Relapsing Remitting Multiple Sclerosis 65 Initiates Enrollment 65 Metastatic Prostate Cancer 65 Graft Versus Host 65 Invasive Breast Cancer 65 Pediatric Patients 65 antiphospholipid syndrome 65 Metabolic Disease 65 acute peripheral arterial 65 Cardiac Resynchronization 65 Receives Orphan Drug Designation 65 Cutaneous T 65 Non Invasive 65 Refractory Angina 65 Mucosal 65 Ileus 65 Carcinomas 65 Pivotal Study 65 Microwave Ablation System 65 plasma kallikrein inhibitor 65 Combination REOLYSIN R 65 Is Well Tolerated 65 malignant ascites 65 CT Angiography 65 Acute Decompensated Heart Failure 65 Hepatocellular Carcinoma 65 Cystatin C 65 Progenitor Cells 65 Percutaneous Transluminal Coronary Angioplasty 65 Castration Resistant Prostate Cancer 65 Nilotinib 65 Subtypes 65 Oesophageal 65 J Clin 65 Phase IIa Clinical Trial 65 ACE Inhibitors 65 pericardial effusion 65 MULTAQ 65 Hormone Receptor Positive 65 Septic Shock 64 Antigen Specific 64 Hypertensive Patients 64 Endologix Powerlink System 64 Hepatic Encephalopathy 64 Trandolapril 64 heparin induced thrombocytopenia 64 Shows Statistically Significant 64 prospective multicenter study 64 macular edema secondary 64 Shows Promising 64 fosbretabulin 64 Gets FDA Clearance 64 Carotid Revascularization Endarterectomy vs. 64 erythema nodosum 64 J Am Soc 64 Demonstrates Significant 64 sunitinib Sutent 64 Angioedema 64 Retinopathy 64 Transcatheter 64 Cryoablation 64 Well Tolerated 64 endoscopic ultrasonography 64 bone marrow reticulin deposition 64 Localized Prostate Cancer 64 Transdermal Patch 64 Vulvar 64 Critical Limb Ischemia 64 Electrical Stimulation 64 Acute Coronary Syndrome 64 Diabetic Foot Ulcer 64 cholelithiasis 64 cytomegalovirus infection 64 choroidal neovascularization 64 Treatment Shows Promise 64 Study Evaluating 64 Stomatitis 64 recurrent glioblastoma multiforme 64 Circulatory Support 64 Skin Structure Infections 64 Non Alcoholic Steatohepatitis 64 Stereotactic Body Radiation Therapy 64 Bisphosphonate 64 Phase IIb Trial 64 Hepatocellular Carcinoma HCC 64 Philadelphia Chromosome Positive 64 Pegylated Liposomal Doxorubicin 64 benign prostatic hypertrophy BPH 64 Decompensated Heart Failure 64 Less Invasive 64 Acute Exacerbations 64 Resistant Hypertension 64 irregular quivering 64 Metastatic Renal Cell Carcinoma 64 Appears Safe 64 Phase 2a Clinical Trial 64 thetreatment 64 underwent resection 64 Proliferative 64 Peptic Ulcer 64 Aortic Stenosis 64 Fundoplication 64 Prostatic 64 Gene Linked 64 Eluting Stent 64 Cell Lymphoma 64 variant angina 64 Heart Transplant Recipients 64 Cognitive Impairment 64 Androgen Deprivation Therapy 64 Heterozygous Familial Hypercholesterolemia 64 Radiofrequency Ablation RFA 64 Contralateral 64 gastrointestinal GI perforation 64 Myelofibrosis 64 haematologic 64 degenerative lumbar 64 Candidiasis 64 metastatic colorectal 64 Diabetic Macular Edema 64 Total Knee Replacement 64 tumor lysis syndrome 64 cerebral vasospasm 64 Estrogen Receptor 64 Pooled Analysis 64 Myelodysplastic Syndromes 64 Pivotal Phase III 64 Inflammatory Markers 64 peripheral arterial occlusive disease 64 Glucocorticoid 64 neovascular 64 Biolimus A9 64 Renal Insufficiency 64 reduce serum phosphate 64 chronic myocardial ischemia 64 BCG refractory carcinoma 64 Test Detects 64 fibrin deposition 64 proliferative diabetic retinopathy 64 Patients Suffering 64 Increased Mortality 64 Relapsed Multiple Myeloma 64 AA Amyloidosis 64 Bacteremia 64 essential thrombocythemia ET 64 Genetic Marker 64 Systemic Sclerosis 64 occlusion PAO 64 choroidal neovascularization CNV 64 Epithelial 64 NMIBC 64 photocoagulation 64 Antiviral Therapy 64 Leber Hereditary Optic Neuropathy 64 pulmonary metastases 64 osteoid osteoma 64 Diabetic Macular Edema DME 64 Personalized Immunotherapy 64 Combo Therapy 64 Arteriovenous 64 HER2 Positive Breast Cancer 64 ALN HPN 64 transplantation HCT 64 First Patient Enrolled 64 Thrombus 64 Single Dose 64 retinal vein occlusion induced 64 Dose Escalation 64 Myocardial 64 Patient Enrollment 64 hip osteonecrosis avascular 64 bronchial hyperresponsiveness 64 Aortic Valve Replacement 64 Myocardial Infarction Study 64 Subgroup Analysis 64 Osteoarthritis Patients 64 Slows Progression 64 Corneal Transplant 64 Controlled Study 64 C Reactive Protein 64 Initiates Phase III 64 Fungal Infections 64 intrathoracic 64 HER2 Positive 64 Clinical Efficacy 64 Subclinical 64 Immune Responses 64 Unstable angina 64 Myoblast 64 deep venous thromboses 64 STRIDE PD 64 Phase IIb Clinical Trial 64 allogeneic hematopoietic stem cell 64 Muscle Wasting 64 Antithrombin 64 Atopic Dermatitis 64 Neoplasms 64 Bevacizumab 64 Disease Modifying 64 Fludara ® 64 Bucindolol Based 64 MKC# MKC# PP 64 Induction Therapy 64 Thrombolysis 64 Cardiopulmonary bypass 64 Eur J 64 Carotid Artery 64 mediastinitis 64 Intravesical 64 Anticoagulants 64 AVAPRO 64 Post Operative 64 Multicenter Study 64 Radical Prostatectomy 64 hepatorenal syndrome 64 smoldering multiple myeloma 64 moderate hepatic impairment 64 debilitating complication 64 Warfarin Coumadin 63 Tacrolimus 63 Autoantibodies 63 Multicenter Randomized 63 pan HDAC inhibitor 63 catheter occlusion 63 systemic lupus erythematosus psoriasis 63 Vertebral Fractures 63 Hip Fractures 63 Infected Patients 63 autosomal dominant polycystic kidney 63 Postmenopausal Women 63 nicardipine 63 Valvular 63 Survival Benefit 63 Urinary tract 63 Initiates Phase II 63 Diabetic nephropathy 63 Clostridium difficile Infection 63 purpura ITP 63 colorectal carcinoma 63 Node Positive 63 Juvenile Idiopathic Arthritis 63 Placebo Controlled Trial 63 nonarteritic anterior ischemic optic 63 Cancer Patients Treated 63 neointimal hyperplasia 63 Cystectomy 63 Lymphoid 63 Transplant Rejection 63 Tolvaptan 63 transabdominal 63 Sonographic 63 cystoid macular edema 63 somatostatin analog 63 Liver Failure 63 Occlusion 63 Autoimmune Disease 63 urothelial carcinoma 63 Bronchiectasis 63 Study Demonstrates 63 Hemorrhagic 63 Duodenal 63 gastric carcinoma 63 Extracellular Matrix 63 systemic amyloidosis 63 variceal hemorrhage 63 Nesiritide 63 Cell Transplants 63 Anti Tumor 63 NAGS deficiency 63 Erythropoietic 63 erythematosus SLE 63 included exfoliative dermatitis 63 transcranial Doppler ultrasound 63 systemic hypotension 63 MGd 63 Dendritic Cells 63 Moxifloxacin 63 Acute Renal Failure 63 myopathies 63 Dasatinib 63 Tumor Targeting 63 Peripheral Artery Disease 63 artery embolization 63 Anticancer Agent 63 Bone Mineral Density 63 Cervical Dysplasia 63 epithelial tumors 63 G CSFs 63 retinal vein occlusion 63 adalimumab Humira 63 Physician Insights 63 keratoplasty 63 candidates Azedra TM 63 Denufosol 63 Orthostatic Hypotension 63 Beta Blockers 63 transarterial 63 Idiopathic pulmonary fibrosis 63 pathologic myopia 63 Vascular Disrupting Agent 63 Bare Metal Stent 63 Aflibercept 63 Hemodialysis Patients 63 valvular heart 63 percutaneous nephrolithotomy 63 ® lenalidomide 63 Neovascularization 63 Phase III Trial 63 Interferon Beta 63 renal failure interstitial lung 63 Granted Orphan Drug 63 HeFH 63 Glucocorticoids 63 Phase Ib Clinical Trial 63 severe oral mucositis 63 Pafuramidine 63 Romiplostim 63 Pulmonary Artery 63 Treatable 63 drug zotarolimus 63 Anticoagulation 63 ADPKD 63 Tasigna prolongs 63 Cilostazol 63 Cytarabine 63 biliary tract cancer 63 Nonalcoholic Fatty Liver Disease 63 Basal Cell 63 renal artery stenting 63 Acute Lung 63 Gastrointestinal Tract 63 BENICAR HCT 63 Synta Announces 63 Allergic Rhinitis 63 See CLINICAL PHARMACOLOGY 63 Peripheral Vascular Disease 63 Left Ventricular Dysfunction 63 Ventilator Associated 63 myeloid metaplasia 63 invasive candidiasis 63 anemia thrombocytopenia 63 proliferative retinopathy 63 brand ciclesonide HFA 63 either acutely decompensated 63 OMNARIS HFA 63 NDA Submission 63 Adenocarcinoma 63 Bosutinib 63 Efficacy Trial 63 dilated cardiomyopathy DCM 63 Paroxysmal Nocturnal Hemoglobinuria PNH 63 Dry Powder Inhalers 63 Ischaemic heart 63 Cardiac Resynchronization Therapy 63 cytoreductive surgery 63 Presents Preclinical Data 63 Melphalan 63 Total Knee Arthroplasty 63 Dosa suffers 63 Circulating Tumor Cells 63 Immunotherapeutic 63 Coronary Artery 63 Hematopoietic 63 Dupuytren Disease 63 Reduces Risk 63 Systemic Lupus Erythematosus SLE 63 Mitral Valve 63 Contrast Agents 63 #-# Full Text 63 Cholesterol Lowering Drug 63 Lymphocytic 63 Retreatment 63 Valve Replacement 63 intravesical therapy 63 MALT lymphoma 63 functional mitral regurgitation 63 Myeloma Patients 63 Aggressive Reduction 63 juvenile idiopathic arthritis 63 arterial calcification 63 Iron Overload 63 Investigational Compound 63 Systemic Lupus Erythematosus 63 alpha1 antitrypsin deficiency 63 mitral stenosis 63 leukoencephalopathy 63 Ischaemic 63 Toxicities 63 Lenalidomide 63 oropharyngeal candidiasis OPC 63 Phase 2b Trial 63 Epratuzumab 63 Suicidality 63 ANCA associated 63 cardiac repolarization 63 SSc 63 disease GERD 63 Cognitive Decline 63 Deferiprone 63 Improve Outcomes 63 cervical lymph nodes 63 Prognostic Value 63 Fibrosis 63 Nano Particles 63 Bone Fracture 63 symptomatic intracranial 63 gefitinib Iressa 63 oesophagitis 63 Lipid Lowering Treatment 63 CP CPPS 63 spinal metastases 63 Factor Receptor 63 Randomized Controlled Trials 63 arthropathy 63 ventricular dysfunction 62 Intracranial Aneurysms 62 metastatic renal 62 EnteroMedics proprietary neuroblocking technology 62 saphenous vein graft 62 oral dual endothelin 62 Ultrasonography 62 Significantly Reduces 62 Known hypersensitivity 62 bronchoalveolar lavage 62 Lung Cancer Patients 62 osteolytic 62 papillary renal cell carcinoma 62 gastro esophageal reflux 62 Vascugel 62 Pegloticase 62 SHPT 62 IL# PE#QQR 62 Clinical Trial Data 62 Arterial Disease 62 Rheumatoid 62 Hepatic 62 dermopathy 62 Leukemias 62 Fluorouracil 62 Interferon Gamma 62 Ultrasensitive 62 Novel Compound 62 peripheral artery 62 Diabetic Retinopathy 62 FDA APPROVES 62 Renal Cell Carcinoma RCC 62 transcranial Doppler 62 TNF Blockers 62 Liprotamase 62 Parathyroid hormone 62 pseudomembranous colitis 62 Dilated Cardiomyopathy 62 Polymerase Inhibitor 62 Improved Survival 62 systolic hypertension 62 Acute Myelogenous Leukemia AML 62 Syncria R 62 Glioblastoma Multiforme GBM 62 Genes Identified 62 Pleural 62 Confirms Efficacy 62 Squamous 62 esophageal candidiasis 62 Ablation 62 Demonstrate Significant 62 Hsp# Inhibitor 62 Synovial 62 gastrointestinal mucositis 62 Protein Linked 62 Endothelial Cells 62 nimodipine 62 Bazedoxifene 62 Balloon Catheters 62 liver resection 62 Small Intestine 62 lung esophageal 62 Enzyme Replacement Therapy 62 Robotic Assisted 62 biliary tract disease 62 See WARNINGS 62 Portal Hypertension 62 Bosentan 62 Treated Patients 62 Monotherapy 62 Desvenlafaxine Succinate 62 LymphoStat B belimumab 62 Parathyroid 62 Tambocor 62 Perfusion 62 stratifying patients 62 giant cell arteritis 62 Cardiac Output 62 Pericardial 62 FDA Clears 62 Controlled Trial 62 including thyroiditis RA 62 vascular insufficiency 62 erlotinib Tarceva ® 62 intravesical infusion therapy 62 neovascularisation 62 Intraocular 62 CYP#A# CYP#D# 62 Invasive Fungal Infections 62 Malignancies 62 gastrointestinal perforation 62 refractory chronic lymphocytic 62 Gastrointestinal GI 62 Follicular Lymphoma 62 serum phosphate 62 Image Guided 62 vitreoretinal disorders 62 Belldegrun 62 diabetic kidney 62 Prospective Multicenter 62 Breast Cancers 62 Helps Predict 62 Insulin Resistance 62 Neovascular AMD 62 Anticoagulant 62 Embolic Protection 62 Demonstrates Sustained 62 Multidetector CT 62 Embolic Protection Device 62 overactive bladder syndrome 62 Glycemic Control 62 Fibroblast 62 Activator CK # 62 Neuropathic 62 systemic autoimmune 62 ELADUR ™ 62 Severe Acne 62 RENAL 62 Multiple Myeloma MM 62 Novel Treatments 62 PICSO ® 62 Premature Infants 62 Non Responders 62 unstable angina UA 62 Hematologic 62 Enoxaparin 62 hypoperfusion 62 External Beam 62 Viral Load 62 vertebrobasilar 62 Blood Pressure Drug 62 metaplasia 62 Gene Variant 62 Friedreich Ataxia FRDA 62 Proteinuria 62 Hepatocellular 62 Study Showed 62 Ventricular 62 percutaneous transluminal coronary angioplasty 62 pancytopenia 62 Venous thromboembolism 62 Prognostic Significance 62 Premenopausal Women 62 Obese Patients 62 Myocardial Infarction TIMI 62 Hyperuricemia 62 Tezampanel 62 Drug Resistant 62 Biocompatibility 62 Urethral 62 Angiotensin Converting Enzyme 62 Significantly Improves 62 Aurora Kinase 62 vWD 62 Newly Diagnosed Multiple Myeloma 62 myomas 62 Epstein Barr Virus 62 Cytotoxicity 62 Mitomycin C 62 Inhibits 62 Virus Infection 62 Randomized Clinical Trial 62 PEGylated interferon beta 1a 62 Antiplatelet 62 Chronic Rhinosinusitis 62 Microvascular 62 Reduces Pain 62 Claudication 62 ergot derivatives 62 failure ADHF 62 TO AVOID PREGNANCY WHILE 62 Shows Efficacy 62 Acute Coronary Syndromes ACS 62 Bronchopulmonary Dysplasia 62 Zorbtive TM 62 Cognitive Deficits 62 paroxysmal nocturnal hemoglobinuria 62 Plaque Psoriasis 62 metastatic neuroendocrine tumors 62 malignant pleural mesothelioma 62 Xelox 62 Prematurity ROP 62 pouchitis 62 Ovarian Cancers 62 Accelerated Partial Breast Irradiation 62 neurogenic bladder 62 JAK2 Inhibitor 62 microvascular disease 62 Antihypertensive 62 venous reflux 62 CTEPH 62 optic neuropathy 62 Carotid artery 62 cystic fibrosis chronic pancreatitis 62 evaluating T DM1 62 metastatic colorectal carcinoma 62 Artery Disease 62 colorectal liver metastases 62 Chemokine Receptor 62 GW# [003] 62 Severe Asthma 62 Chronic Prostatitis 62 ThermoDox R 62 treat atrial flutter 62 primary immunodeficiency PI 62 VEGF induced 62 elevated IOP 62 granulomatous 62 Serious Infections 62 Hyperplasia 62 Atrial 62 EVIZON TM 62 alpha1 antitrypsin AAT deficiency 62 FASLODEX 62 idiopathic pulmonary 62 decortication 62 Radiation Induced 62 thyrotoxicosis 62 evaluate ZFP Therapeutic 62 coagulation abnormalities 62 myoclonus 62 Spinal Fusion 62 Post Herpetic Neuralgia 62 Sevelamer 62 delivers fluocinolone acetonide FA 62 Postmenopausal 62 benign neoplasms 62 protein tyrosine phosphatase 1B 62 Ranolazine 62 methicillin susceptible Staphylococcus aureus 62 Neovascular 62 Glioma 62 pemphigus vulgaris 62 hypokalemia hypomagnesemia 62 proliferator activated receptor 62 Arrhythmias 62 Proc Am Soc